Corrigendum: Association of p53 Codon 72 Genotypes and Clinical Outcome in Human Papillomavirus-Infected Lung Cancer Patients (Annals of Thoracic Surgery (2013) 95(4) (1196–1203) (S0003497513001227) (10.1016/j.athoracsur.2012.12.059));Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients

Annals of Thoracic Surgery

Volumn 95, Issue 4, 2013, Pages 1196-1203

  Chen, Shih Pin ^b,c   Hsu, Nan Yung ^a,d   Wu, Jeng Yuan ^e,f   Chen, Chih Yi ^g   Chou, Ming Chih ^b,c   Lee, Huei ^a   Cheng, Ya Wen ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^f TZU CHI UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SMOKING;

EID: 84875342440     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2017.01.050     Document Type: Erratum

References (25)

1. C.J. Chen, H.Y. Wu, Y.C. Chuang Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan Anticancer Res 10 1990 971 976
2. Y.W. Cheng, H.L. Chiou, G.T. Sheu The association of human papillomavirus 16/18 infection with lung cancer among non-smoking Taiwanese women Cancer Res 61 2001 2799 2803
3. Y.W. Cheng, M.F. Wu, J. Wang Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation Cancer Res 67 2007 10686 10693
4. C.R. Leemans, B.J. Braakhuis, R.H. Brakenhoff The molecular biology of head and neck cancer Nat Rev Cancer 11 2011 9 22
5. N.J. Veldhuijzen, P.J. Snijders, P. Reiss, C.J. Meijer, J.H. van de Wijgert Factors affecting transmission of mucosal human papillomavirus Lancet Infect Dis 10 2010 862 874
6. K. Baltzell, G.C. Buehring, S. Krishnamurthy, H. Kuerer, H.M. Shen, J.D. Sison Limited evidence of human papillomavirus on breast tissue using molecular in situ methods Cancer 118 2012 1212 1220
7. B.E. Hoots, J.M. Palefsky, J.M. Pimenta, J.S. Smith Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions Int J Cancer 124 2009 2375 2383
8. H. zur Hausen Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis J Natl Cancer Inst 92 2000 690 698
9. V. Graziano, V. De Laurenzi Role of p53 in cancer development Biochim Biophys Acta 1816 2011 57 66
10. L. Yan, D. Zhang, C. Chen TP53 Arg72Pro polymorphism and lung cancer risk: a meta-analysis Int J Cancer 125 2009 2903 2911
11. A. Matakidou, T. Eisen, R.S. Houlston TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis Mutagenesis 18 2003 377 385
12. A. Storey, M. Thomas, A. Kalita Role of a p53 polymorphism in the development of human papillomavirus-associated cancer Nature 393 1998 229 234
13. X. Ji, A.S. Neumann, E.M. Sturgis p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers Carcinogenesis 29 2008 875 879
14. S.J. Klug, M. Ressing, J. Koenig TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies Lancet Oncol 10 2009 772 784
15. Y. Soini, K. Nuorva, D. Kamel Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma Thorax 51 1996 887 893
16. J.Y. Han, G.K. Lee, D.H. Jang, S.Y. Lee, J.S. Lee Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer Cancer 113 2008 799 807
17. H.H. Nelson, M. Wilkojmen, C.J. Marsit, K.T. Kelsey TP53 mutation, allelism and survival in non-small cell lung cancer Carcinogenesis 26 2005 1770 1773
18. Y.C. Wang, C.Y. Chen, S.K. Chen, Y.Y. Chang, P. Lin p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis Clin Cancer Res 5 1999 129 134
19. W.P. Chien, R.H. Wong, T.C. Wu, Y.W. Cheng, C.Y. Chen, H. Lee Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer Ann Surg Oncol 16 2009 1918 1924
20. H.H. Wu, Y.C. Chu, L. Wang Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer Ann Surg Oncol 2012; Jun 12 [Epub ahead of print]
21. A. Rogler, M. Rogenhofer, A. Borchardt P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype Pathobiology 78 2011 193 200
22. X. Chen, E.M. Sturgis, C.J. Etzel, Q. Wei, G. Li p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers Cancer 113 2008 3307 3314
23. M.L. Tornesello, M.L. Duraturo, V. Guida Analysis of TP53 codon 72 polymorphism in HPV-positive and HPV-negative penile carcinoma Cancer Lett 269 2008 159 164
24. S. Oliveira, H. Sousa, A.M. Santos The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells J Med Virol 80 2008 424 429
25. W. Yang, Y. Zhang, X. Tian, T. Ning, Y. Ke p53 Codon 72 polymorphism and the risk of esophageal squamous cell carcinoma Mol Carcinogene 47 2008 100 104